Cargando…
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome
BACKGROUND: Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) are present in a subset of aquaporin-4 (AQP4)-IgG-negative patients with optic neuritis (ON) and/or myelitis. Little is known so far about brainstem involvement in MOG-IgG-positive patients. OBJECTIVE: To investigate the frequency,...
Autores principales: | Jarius, Sven, Kleiter, Ingo, Ruprecht, Klemens, Asgari, Nasrin, Pitarokoili, Kalliopi, Borisow, Nadja, Hümmert, Martin W., Trebst, Corinna, Pache, Florence, Winkelmann, Alexander, Beume, Lena-Alexandra, Ringelstein, Marius, Stich, Oliver, Aktas, Orhan, Korporal-Kuhnke, Mirjam, Schwarz, Alexander, Lukas, Carsten, Haas, Jürgen, Fechner, Kai, Buttmann, Mathias, Bellmann-Strobl, Judith, Zimmermann, Hanna, Brandt, Alexander U., Franciotta, Diego, Schanda, Kathrin, Paul, Friedemann, Reindl, Markus, Wildemann, Brigitte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088671/ https://www.ncbi.nlm.nih.gov/pubmed/27802825 http://dx.doi.org/10.1186/s12974-016-0719-z |
Ejemplares similares
-
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin
por: Jarius, Sven, et al.
Publicado: (2016) -
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
por: Jarius, Sven, et al.
Publicado: (2016) -
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
por: Jarius, Sven, et al.
Publicado: (2020) -
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients
por: Pache, Florence, et al.
Publicado: (2016) -
Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Disease: CHANCE(NMO) Study
por: Hümmert, Martin W., et al.
Publicado: (2022)